Clinical significance of anti-filaggrin antibody recognizing uncitrullinated filaggrin in rheumatoid arthritis

Experimental and Molecular Medicine

Volumn 37, Issue 6, 2005, Pages 546-552

  Choi, Kyung Ho ^a   Eun, Bong Lee ^a   Chang, Dal Yoo ^a   Han, Joo Baek ^a   Seong, Wook Kang ^a   Ki, Chul Shin ^a   Yun, Jong Lee ^a   Hyun, Ah Kim ^a   Jeon, Ju Hong ^a   Kim, Chai Wan ^a   Shin, Dong Myung ^a   Kim, In Gyu ^a   Yeong, Wook Song ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Autoimmune; Cyclin citrullinated peptide; Diseases; Filaggrin; Immunoenzyme techniques; Rheumatoid arthritis

Indexed keywords

ANTINUCLEAR ANTIBODY; C REACTIVE PROTEIN; CITRULLINE; FILAGGRIN; IMMUNOGLOBULIN G; RHEUMATOID FACTOR;

ADULT; ANKYLOSING SPONDYLITIS; ANTIBODY TITER; ARTHRALGIA; ARTICLE; BLOOD ANALYSIS; COMPARATIVE STUDY; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PAIN ASSESSMENT; RHEUMATOID ARTHRITIS; SERUM; STATISTICAL SIGNIFICANCE; SYSTEMIC LUPUS ERYTHEMATOSUS; VISUAL ANALOG SCALE;

EID: 31344461281     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2005.67     Document Type: Article

References (31)

1. Aho K, von Essen R, Kurki P, Palosuo T, Helliövaara M. Antikeratin antibody and antiperinuclear factor as markers for subclinical rheumatoid disease process. J Rheumatol 1993;20:1278-81
2. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1998;31:315-24
3. Bas S, Genevay S, Meyer O, Gabay C. Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis. Rheumatology 2003;42:677-80
4. Berthelot JM, Maugars Y, Prost A, Youinou P. Rheumatoid arthritis and filaggrin, a review. Rev Rhum 1995;62:127-38
5. Callahan LF, Brooks RH, Summey JA, Pincus T. Quantitative pain assessment for routine care of rheumatoid arthritis patients, using a pain scale based on activities of daily living and a visual analog pain scale. Arthritis Rheum 1987;30:630-6
6. Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 1993;36:729-40
7. Gan SQ, McBride W, Idler WW, Markova N, Steinert M. Organization, structure, and polymorphisms of the human profilaggrin gene. Biochem 1990;29:9432-40
8. Girelli F, Foschi FG, Bedeschi E, Calderoni V, Stefanini GF, Martinelli MG. Is Anti Cyclic citrullinated peptide a useful laboratory test for the diagnosis of rheumatoid arthritis? Allergy Immunol 2004;36:127-30
9. Hochberg MC, Chang RW, Dwosh I, Lindsey S, Pincus T, Wolfe F. The American College of Rheumatology 1991 revised criteria for the classification of global functional-status in rheumatoid arthritis. Arthritis Rheum 1992;35:498-502
10. Hoet RM, Boerhooms AM, Arends M, Ruiter DJ, van Venrooij WJ. Antiperinuclear factor, a marker autoantibody for rheumatoid arthritis: colocalization of the perinuclear factor and profilaggrin. Ann Rheum Dis 1991;50:611-8
11. Kellgren JH. Epidemiology of rheumatoid arthritis. Arthritis Rheum 1996;9:658-74
12. Kroot EJA, de Jong BAW, van Leeuwen MA, Swinkels H, van den Hoogen FHJ, van't Hof M. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent onset rheumatoid arthritis. Arthritis Rheum 2000;43:1831-5
13. Kurki P, von Essen R, Kaarela K, Isomäki H, Palosuo T, Aho K. Antibody to stratum corneum (anti-keratin antibody) and antiperinuclear factor: markers for progressive rheumatoid arthritis. Scand J Rheumatol 1997;26:346-9
14. Lee P, Baxter A, Dick WC, Webb J. An assessment of grip strength measurement in rheumatoid arthritis. Scand J Rheumatol 1974;3:17-23
15. McKinley-Grant LJ, Idler WW, Bernstein IA, Parry DA, Cannizzaro L, Croce CM. Characterization of a cDNA clone encoding human filaggrin and localization of the gene to chromosome region 1q21. Proc Natl Acad Sci 1989;86:4848-52
16. Ménard HA, El Amine M, Després N. Rheumatoid arthritis associated autoimmune systems. J Rheumatol 1998;25:835-7
17. Nienhuis RLF, Mandema E, Smids C. A new serum factor in patients with rheumatoid arthritis, the antiperinuclear factor. Ann Rheum Dis 1964;23:302-5
18. Paimela L, Gripenber M, Kurki P, Leirisalo-Repo M. Anti-keratin antibodies: diagnostic and prognostic markers for early rheumatoid arthritis. Ann Rheum Dis 1992;51:743-6
19. Palosuo T, Lukka M, Alenius H, Kalkkinen N, Aho K, Kurki P. Purification of filaggrin from human epidermis and measurement of antifilaggrin autoantibodies in sera from patients with rheumatoid arthritis by an enzyme-linked immunosorbent assay. Int Arch Allergy Immunol 1998;115:294-302
20. Ritchie DM, Boyle JA, Mclnnes JM, Jasani MK, Dalakos TG, Grieveson P. Clinical studies with articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 1968;37:393-406
21. Schellenkens GA, de Jong BAW, van den Hoogen FHJ, van de Putte LBA. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998;101:273-81
22. Schellekens GA, Visser H, de Jong BA, Van den Hoogen FH, Hazes JM, Breedveld FC, Van Venrooij WJ. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000;43:155-63
23. Schrohenloher RE, Bridges SL, Koopman WJ. Rheumatoid factor. In Arthritis and allied conditions, a textbook of rheumatology (Koopman WJ eds), 1997, 1109-30, Williams & Wilkins, Baltimore
24. Sebbag M, Simon M, Vincent C, Masson-Bessiére C, Girbal E, Durieux JJ. The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies. J Clin Invest 1995;95:2672-9
25. Simon M, Girbal E, Sebbag M, Gomès-Daudrix V, Vincent C, Salama G. The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "anti-keratin antibodies", autoantibodies specific for rheumatoid arthritis. J Clin Invest 1993;92:1387-93
26. Slack SH, Mannik M, Dale BA. Diagnostic value of antibodies to filaggrin in rheumatoid arthritis. J Rheumatol 1998;25:847-51
27. Steinbocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. JAMA 1949;140:659-62
28. Vincent C, Simon M, Sebbag M, Girbal-Neuhauser E, Durieux J, Cantagrel A. Immunoblotting detection of autoantibodies to human epidermis filaggrin: a new diagnostic test for rheumatoid arthritis. J Rheumatol 1998;25:838-46
29. Vincent C, Nogueira L, Clavel C, Sebbag M, Serre G. Autoantibodies to citrullinated proteins: ACPA. Autoimmunity 2005;38:17-24
30. Westgeest AAA, Boerbooms AMT, Jongmans M, Vandenbroucke JP, Vierwinden G, van de Putte LBA. Antiperinuclear factor: indicator of more severe disease in seronegative rheumatoid arthritis. J Rheumatol 1987;14:893-7
31. Young BJJ, Mallya RK, Leslie RDG, Clark CJM, Hamblin TJ. Antikeratin antibodies in rheumatoid arthritis. BMJ 1979;2:97-9